| P50 | author | Ann C Mertens | Q89914242 |
| | Sharon M Castellino | Q90365360 |
| | Melissa M. Hudson | Q90661800 |
| | Les Robison | Q91435233 |
| | Kevin C Oeffinger | Q98166561 |
| | Pamela J Goodman | Q114449167 |
| | Wendy Leisenring | Q75026076 |
| P2093 | author name string | Neyssa Marina | |
| | Stephanie M Smith | |
| | Meagan Lansdale | |
| P2860 | cites work | NIH Consensus Statement on Management of Hepatitis C: 2002 | Q75442808 |
| | Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer | Q77729258 |
| | Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 |
| | Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Hepatitis C infection among survivors of childhood cancer. | Q33916809 |
| | Chronic health conditions in adult survivors of childhood cancer | Q34573463 |
| | Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation | Q35079470 |
| | Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study | Q37121635 |
| | The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research | Q37181672 |
| | Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. | Q37334833 |
| | Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy | Q39548769 |
| | Projecting future complications of chronic hepatitis C in the United States | Q40594872 |
| | The Declining Risk of Post-Transfusion Hepatitis C Virus Infection | Q42981465 |
| | Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease | Q42993635 |
| | Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients | Q43039062 |
| | The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study | Q43589291 |
| | The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort | Q44698756 |
| | Chronic hepatitis C virus infection after treatment for pediatric malignancy. | Q45761401 |
| | Changing trends in hepatitis C-related mortality in the United States, 1995-2004. | Q46370317 |
| | Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. | Q50587051 |
| | Epidemiology of hepatitis C in the United States. | Q50656203 |
| | Health Status of Adult Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study | Q50731084 |
| | Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. | Q55035762 |
| | Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study | Q71539407 |
| | Donor transaminase and recipient hepatitis. Impact on blood transfusion services | Q71558917 |
| | Estimating future hepatitis C morbidity, mortality, and costs in the United States | Q73073538 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| | childhood cancer | Q5097977 |
| | Childhood Cancer Survivor Study | Q63830302 |
| P304 | page(s) | 974-982 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study | |
| P478 | volume | 116 | |